$35.21 1.21 (+3.56%)
11/27/2009 1:00 PM

Abraxis BioScience, Inc. (ABII)

CAPS Rating: 4 out of 5

Results 1 - 5 of 5

Recs

2
Member Avatar SolarisKing (27.57) Submitted: 9/12/2009 2:57:23 PM : Outperform Start Price: $26.50 ABII Score: +26.89

This is a real company with a real product. If the numbers below are accurate, they are a good buy.

VS industry:

Price to Book (MRQ) 1.19 3.72
Price to Tangible Book (MRQ) 2.20 8.52

LT Debt to Equity (MRQ) 0.00 0.38
Total Debt to Equity (MRQ) 0.00 0.42

Recs

1
Member Avatar kenc132000 (90.84) Submitted: 8/19/2009 11:19:41 AM : Outperform Start Price: $25.85 ABII Score: +26.09

New 52 week low. Has declined by 2/3 from 52 week high. New management in place. Oncology products company with promising pipeline.

Recs

1
Member Avatar anmw (< 20) Submitted: 6/8/2008 1:29:22 PM : Underperform Start Price: $66.51 ABII Score: +29.96

If a history is any indication, then consider the PFE. A few year ago, it was trading at 150 times 12 month trail earning or about $150.00 per share. Within two-three week after achieving 150 times, it dived to $100 per share. Rest is his a history.

Newness doesn't justify 179 times. It seens a but scart to me. This is my way of kicking some tires.

Recs

0
Member Avatar fasial (< 20) Submitted: 5/9/2008 1:18:58 PM : Underperform Start Price: $61.89 ABII Score: +25.07

i may trust here

Recs

2
Member Avatar TMFBiologyFool (90.99) Submitted: 3/27/2008 1:11:42 AM : Outperform Start Price: $60.25 ABII Score: -26.23

One drug on the market with a nice platform to build similar drugs. The spin off (and ticker change) has made this an unknown company which could cause its stock price to falter a little. Still there's points to be made in unknown companies.

Holding the actual dollars away from this one until it gets regular with its earnings announcements. We're less than a week away from the end of the 1st quarter and there's no sign of 4th quarter financial info. The spin off is holding things up, but I figure it makes since to invest in companies based on current information.

Results 1 - 5 of 5

Featured Broker Partners